glp-1 ulcerative colitis Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential GLP-1 Therapy May Offer Added

Currently in the UK, injectable GLP-1 receptor agonists such as semaglutide (Ozempic) and dulaglutide (Trulicity) are well-established treatments recommended by NICE (NG28) for specific indications in type 2 diabetes management, with some formulations also approved for weight management

This study was done in patients who had both Type 2 Diabetes and IBD and observed clinical outcomes in patients who were taking GLP-1 agonist or DPP-4 inhibitors, another type of glucose-lowering medication

[1] Injection site reactionssuch as redness, swelling, or bruisingare generally mild and self-limited

Our Members Asked: Do Probiotics, Such as Those by Bioma and Pendulum, Boost GLP-1 to Help with Weight Loss

Setting clear goals for GLP-1 spend and/or usage